quant Healthcare Fund
NAV
₹18.8
as of 6 Oct 2026
quant Healthcare Fund is an open-ended Sectoral/ Thematic scheme from quant Mutual Fund managing ₹397 crore (as of 31 Jul 2026). Its Direct-plan NAV is ₹18.8 as of 6 Oct 2026. The expense ratio is 1.49% a year. Managed by Sanjeev Sharma. This page is factual data only – it carries no rating and no recommendation.
Key facts
- Expense ratio
- 1.49% / yr
- as of 31 Aug 2026
- Fund size
- ₹397 crore
- as of 31 Jul 2026
- Exit load
- 1%
- SIP available
- Yes
- Launched
- 18 Jul 2023
- ISIN
- INF966L01CD0
₹100 invested, fund vs category
The category line is the average of the funds in this category, built from nyvo’s own NAV data.
Rebased to 100data to 5 Oct 2026Benchmark: Nifty 500 Healthcare TRI
quant Healthcare Fund
₹186
+86% on ₹100 over 3.2 yrs
Sectoral/ Thematic average
₹188
+88% on ₹100 over 3.2 yrs
Returns vs category
| Window | Fund | Category avg | Gap |
|---|---|---|---|
| 3 months | 2.46% | – | – |
| 6 months | 19.64% | – | – |
| 1 year | 17.22% | – | – |
| 3 years (CAGR) | 20.25% | – | – |
No category average is available for this fund. Short windows are noise; the 3 and 5-year rows are the record. Past returns do not predict future returns.
A single return number depends on its start date. These are ALL the overlapping holding periods, so the worst case is visible – read that number first.
1-year holding periods
- Worst
- -10.9%
- Median
- 9.3%
- Best
- 63.5%
28 windows over the last 39 months, stepped monthly; 71% ended positive. Worst window began 2 Sept 2024. Windows overlap – this is the range of past start dates, not a probability of anything.
3-year holding periods (per year)
- Worst
- 20.1%
- Median
- 21.5%
- Best
- 22.3%
4 windows over the last 39 months, stepped monthly; 100% ended positive. Worst window began 3 Oct 2023. Windows overlap – this is the range of past start dates, not a probability of anything.
Risk, measured
- Sharpe ratio (3Y)
- 0.86
- Sortino ratio (3Y)
- 1.49 vs category 1.63
- Standard deviation (3Y)
- 18.15%
- Beta (3Y)
- 0.98
- Alpha (3Y)
- 0.28%
Distance below its own peak
Every dip below 0 is the fund trading under a previous high – how deep and for how long is what a drawdown feels like.
Deepest fall
-22.5%
Right now
-4.6% below peak
Ahead of its benchmark in 50% of months (window: 3y, monthly) – benchmark: Nifty 500 Healthcare TRI, name shown only.
Where the money actually is
Equity
99.5%
Cash
0.5%
Whole-portfolio split, as of 31 Jul 2026. Equity here is the NET position: this fund holds shares and sells futures against them, so the two largely cancel. The holdings below are gross, before that offset.
What it owns
25 positions · top 10 = 85.6%
Market-cap mix
Large 9.9%Mid 39.5%Small 50.1%Other 0.5%
as of 31 Jul 2026
Holdings by sector
Healthcare(4 in top 10)62.8%
- GlaxoSmithKline Pharmaceuticals Ltd9.93%
- Concord Biotech Ltd9.66%
- Aster DM Quality Care Ltd Ordinary Shares9.25%
- SMS Pharmaceuticals Ltd7.27%
Consumer Defensive(1 in top 10)9.3%
- Zydus Wellness Ltd9.33%
Technology(1 in top 10)7.9%
- HFCL Ltd7.89%
- Basic Materials0.3%
Sectors marked ▶ expand to show this fund’s top-10 holdings in that sector. Holdings as of 31 Jul 2026. Portfolio turnover 134.4% a year.
Other top holdings
- Nca-Net Current Assets17.89%
- Treps 03-Aug-2026 Depo 10matures 3 Aug 202611.59%
- Future on Divi's Laboratories Ltdderivativematures 25 Aug 20269.93%
- Future on Glenmark Pharmaceuticals Ltdderivativematures 25 Aug 20269.21%
Rows marked derivative are futures positions held against the shares listed beside them. A stock and its future largely cancel, so do not add the two together. Exposure figures are gross: funds that use derivatives (arbitrage, hedged books) hold offsetting positions, so concentration and turnover can read above 100%.
The businesses it owns
- P/E (trailing)
- 40.3
- P/B
- 5.7
- Dividend yield
- 0.5%
- Net margin
- 16.2%
- Earnings growth
- 25.9%
- Avg market cap
- ₹32,793 crore
Money in, money out
- Net flow, 12 months
- −₹58 cr
- Net flow, 3 months
- −₹3 cr
as of 31 Jul 2026. Flows follow performance more than they predict it.
Quick answers
- What is the NAV of quant Healthcare Fund?
- ₹18.8 per unit as of 6 Oct 2026 (Direct plan, growth). NAV is declared daily on working days.
- What is the expense ratio of quant Healthcare Fund?
- 1.49% a year for the Direct plan, as of 31 Aug 2026.
- How large is quant Healthcare Fund?
- ₹397 crore under management as of 31 Jul 2026, in the Sectoral/ Thematic category.
- How risky is quant Healthcare Fund?
- Its SEBI Riskometer reading is "Very High Risk". One sector, one story. The most-launched shelf on the map, by far.
- What is the worst 3-year return of quant Healthcare Fund?
- 20.1% a year – the weakest of 4 overlapping 3-year holding periods, beginning 3 Oct 2023. The median was 21.5% and 100% of those windows ended positive. Windows overlap, so this is the range of past start dates, not a probability.
- Who manages quant Healthcare Fund?
- Sanjeev Sharma, managing this fund for 3.1 years.
Where this fund sits
Its shelf, all funds
St · Sectoral / thematic →
One sector, one story. The most-launched shelf on the map, by far.
The money map
How big this shelf is in India →
The whole industry sized by real money, from AMFI’s monthly data.
Side by side
Compare this fund →
Put it next to any other fund – growth, returns, risk and cost in one table.
One bet or two?
Check its overlap →
See whether it owns the same stocks as your other funds.
Other Sectoral/ Thematic funds
- ICICI Prudential India Opportunities Fund₹38,338 crore
- ICICI Prudential Business Cycle Fund₹15,873 crore
- Quant Infrastructure Fund₹3,146 crore
- quant Quantamental Fund₹1,642 crore
- Taurus Ethical Fund₹434 crore
- Bajaj Finserv Healthcare Fund₹406 crore
- Invesco India ESG Integration Strategy Fund₹395 crore
- ITI Banking and Financial Services Fund₹388 crore
Data: nyvo research systems; each block above states its own as-of date, and blocks with no data for this fund are omitted rather than estimated. NAV updates daily on working days. The benchmark (Nifty 500 Healthcare TRI) is named for reference only; its values are licensed and never shown. This page is factual information about one scheme. It is not investment advice, not a recommendation, and it carries no rating of any kind. Past performance does not predict future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.